| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/15/2023 | 134.48% | Guggenheim | $38 → $34 | Maintains | Buy |
| 11/10/2023 | 106.9% | Stifel | $35 → $30 | Maintains | Buy |
| 05/16/2023 | 51.72% | JP Morgan | $23 → $22 | Maintains | Overweight |
| 05/24/2022 | 175.86% | Guggenheim | → $40 | Initiates Coverage On | → Buy |
| 05/24/2022 | 106.9% | SVB Leerink | → $30 | Initiates Coverage On | → Outperform |
| 05/24/2022 | 65.52% | JP Morgan | → $24 | Initiates Coverage On | → Overweight |
| 05/24/2022 | 134.48% | Stifel | → $34 | Initiates Coverage On | → Buy |
What is the target price for HilleVax (HLVX)?
The latest price target for HilleVax (NASDAQ: HLVX) was reported by Guggenheim on November 15, 2023. The analyst firm set a price target for $34.00 expecting HLVX to rise to within 12 months (a possible 134.48% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HilleVax (HLVX)?
The latest analyst rating for HilleVax (NASDAQ: HLVX) was provided by Guggenheim, and HilleVax maintained their buy rating.
When is the next analyst rating going to be posted or updated for HilleVax (HLVX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HilleVax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HilleVax was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.
Is the Analyst Rating HilleVax (HLVX) correct?
While ratings are subjective and will change, the latest HilleVax (HLVX) rating was a maintained with a price target of $38.00 to $34.00. The current price HilleVax (HLVX) is trading at is $14.50, which is out of the analyst's predicted range.